Cargando…

Correction to NADH:Cytochrome b(5) Reductase and Cytochrome b(5) Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene

Detalles Bibliográficos
Autores principales:	Stiborová, Marie, Indra, Radek, Moserová, Michaela, Frei, Eva, Schmeiser, Heinz H., Kopka, Klaus, Phillips, David H., Arlt, Volker M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030682/ https://www.ncbi.nlm.nih.gov/pubmed/27575721 http://dx.doi.org/10.1021/acs.chemrestox.6b00283

Ejemplares similares

NADH:Cytochrome b(5) Reductase and Cytochrome b(5) Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene
por: Stiborová, Marie, et al.
Publicado: (2016)

Cytochrome b(5) impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b(5)/P450 reductase null (HBRN) mice
por: Reed, Lindsay, et al.
Publicado: (2018)

NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[a]pyrene catalyzed with rat hepatic microsomes and cytochrome P450 1A1
por: Stiborová, Marie, et al.
Publicado: (2016)

The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers
por: Šulc, Miroslav, et al.
Publicado: (2016)

Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[a]pyrene in prokaryotic and eukaryotic expression systems
por: Stiborová, Marie, et al.
Publicado: (2017)

Application of hepatic cytochrome b(5)/P450 reductase null (HBRN) mice to study the role of cytochrome b(5) in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
por: Reed, Lindsay, et al.
Publicado: (2019)

Induced expression of microsomal cytochrome b(5) determined at mRNA and protein levels in rats exposed to ellipticine, benzo[a]pyrene, and 1-phenylazo-2-naphthol (Sudan I)
por: Stiborová, Marie, et al.
Publicado: (2016)

Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo
por: Dračínská, Helena, et al.
Publicado: (2016)

Cytochrome b(5) plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine
por: Stiborová, Marie, et al.
Publicado: (2017)

Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2
por: Aimová, Dagmar, et al.
Publicado: (2008)

Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine
por: Mrízová, Iveta, et al.
Publicado: (2016)

Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase
por: Reed, Lindsay, et al.
Publicado: (2020)

The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes
por: Stiborová, Marie, et al.
Publicado: (2014)

Optimalization of preparation of apo-cytochrome b(5) utilizing apo-myoglobin
por: Mrázová, Barbora, et al.
Publicado: (2008)

Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats
por: Stiborová, Marie, et al.
Publicado: (2018)

Distribution of valence electrons of the flavin cofactor in NADH-cytochrome b(5) reductase
por: Takaba, Kiyofumi, et al.
Publicado: (2017)

Structural Features of Cytochrome b(5)–Cytochrome b(5) Reductase Complex Formation and Implications for the Intramolecular Dynamics of Cytochrome b(5) Reductase
por: Gutiérrez-Merino, Carlos, et al.
Publicado: (2021)

Defining the in Vivo Role for Cytochrome b(5) in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b(5)
por: Finn, Robert D., et al.
Publicado: (2008)

Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches
por: Martínek, Václav, et al.
Publicado: (2017)

Rat cytochromes P450 oxidize 3-aminobenzanthrone, a human metabolite of the carcinogenic environmental pollutant 3-nitrobenzanthrone
por: Mizerovská, Jana, et al.
Publicado: (2008)

Kinetic and Structural Characterization of the Effects of Membrane on the Complex of Cytochrome b(5) and Cytochrome c
por: Gentry, Katherine A., et al.
Publicado: (2017)

Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1
por: Milichovský, Jan, et al.
Publicado: (2016)

Cytochrome P450 Monooxygenase-Mediated Metabolic Utilization of Benzo[a]Pyrene by Aspergillus Species
por: Ostrem Loss, Erin M., et al.
Publicado: (2019)

PB2558: REFERENCE VALUES FOR METHEMOGLOBIN LEVEL AND NADH-CYTOCHROME B5 REDUCTASE ACTIVITY IN TUNISIAN POPULATION.
por: Bouatrous, Emna, et al.
Publicado: (2023)

Structure of cytochrome b (5) unique to tardigrades
por: Fukuda, Yohta, et al.
Publicado: (2020)

The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice
por: Krais, Annette M., et al.
Publicado: (2015)

Development and validation of a spectrophotometric assay for measuring the activity of NADH: cytochrome b5 reductase in human tumour cells.
por: Barham, H. M., et al.
Publicado: (1996)

Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH‐Cytochrome B5 Reductase Gene
por: Shino, H., et al.
Publicado: (2018)

Insights into the Role of Substrates on the Interaction between Cytochrome b(5) and Cytochrome P450 2B4 by NMR
por: Zhang, Meng, et al.
Publicado: (2015)

Analysis of benzo[a]pyrene metabolites formed by rat hepatic microsomes using high pressure liquid chromatography: optimization of the method
por: Moserová, Michaela, et al.
Publicado: (2009)

A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches
por: Stiborová, Marie, et al.
Publicado: (2015)

Regulation of Hemocytes in Drosophila Requires dappled Cytochrome b5
por: Kleinhesselink, Kurt, et al.
Publicado: (2011)

Cytochrome b(5) reductase and the control of lipid metabolism and healthspan
por: Martin-Montalvo, Alejandro, et al.
Publicado: (2016)

Optimization of Multiparameters for Increased Yields of Cytochrome B5 in Bioreactors
por: Pereira, Ricardo F. S., et al.
Publicado: (2021)

Cytochrome b5 reductases: Redox regulators of cell homeostasis
por: Hall, Robert, et al.
Publicado: (2022)

Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells
por: Heintze, Tamara, et al.
Publicado: (2021)

Interaction of Thalassia testudinum Metabolites with Cytochrome P450 Enzymes and Its Effects on Benzo(a)pyrene-Induced Mutagenicity
por: Delgado-Roche, Livan, et al.
Publicado: (2020)

ZONATION OF HEMOPROTEIN P-450 AND CYTOCHROME b (5) IN THE ADRENOCORTEX OF MAMMALS
por: Ichikawa, Yoshiyuki, et al.
Publicado: (1970)

Synthesis of rat liver microsomal cytochrome b5 by free ribosomes
Publicado: (1980)

Oxidation of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxy-naphthalene (Sudan I) by cytochromes P450 and peroxidases: a comparative study
por: Stiborová, Marie, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_e3pet5h0e2uim99hgsivh9789g